Artivion Inc. (CRY)
17.88
0.25 (1.42%)
At close: Jan 24, 2022, 5:00 AM
1.42% (1D)
| Bid | n/a |
| Market Cap | 725.15M |
| Revenue (ttm) | 388.54M |
| Net Income (ttm) | -13.36M |
| EPS (ttm) | 0.042 |
| PE Ratio (ttm) | 425.7142857142857 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 257,460 |
| Avg. Volume (20D) | 200,073 |
| Open | 17.64 |
| Previous Close | 17.63 |
| Day's Range | 17.49 - 18.22 |
| 52-Week Range | 16.61 - 32.34 |
| Beta | 1.53 |
About CRY
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita ...
Industry Medical - Devices
Sector Healthcare
IPO Date Feb 12, 1993
Employees 1,200
Stock Exchange NYSE
Ticker Symbol CRY
Website https://artivion.com